Browsing Search Results

Matched Description: -sensitive Gi proteins. It is involved in organogenesis, hematopoiesis, and the immune response … . Chemokine stromal cell-derived factor 1 (SDF-1) binds CXCR4. CXCR4 is also a co-receptor for HIV and is … adenylyl cyclase and activates tyrosine kinases, while activated guanine nucleotide binding protein beta … and gamma activate PI3K - regulating gene transcription, cell migration, and cell adhesion. PLC is … activated to cause the cleavage of PIP2 to IP3 and DG. This leads to the increase of calcium from the

Matched Description: -sensitive Gi proteins. It is involved in organogenesis, hematopoiesis, and the immune response … . Chemokine stromal cell-derived factor 1 (SDF-1) binds CXCR4. CXCR4 is also a co-receptor for HIV and is … adenylyl cyclase and activates tyrosine kinases, while activated guanine nucleotide binding protein beta … and gamma activate PI3K - regulating gene transcription, cell migration, and cell adhesion. PLC is … activated to cause the cleavage of PIP2 to IP3 and DG. This leads to the increase of calcium from the

Matched Description: , free radicals, and UV irradiation. It can also respond to bacterial and viral antigens; therefore … and immune diseases (and more) can be related to the incorrect regulation of the NF-κB complex. The … ), and the noncanonical (or alternative) pathway, which selectively responds to a specific group of … stimuli, such as groups of ligands of a subset of TNFR superfamily members (e.g. LTβR, BAFFR, CD40 and … RANK). Both pathways are important for regulating immune and inflammatory responses despite their differences in signalling mechanism.

Matched Description: pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor … agonist which acts in the brain, spinal cord, and peripherally. This means it reduces sympathetic … nervous system tone, and causes respiratory depression and analgesia. Remifentanil binds to mu opioid … adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease … neurotransmitters such as GABA is inhibited. Opioids close N-type voltage-operated calcium channels and open

Matched Description: Aceprometazine is a is a drug with neuroleptic and anti-histamine properties. Although not widely … sedation by being able to cross the blood-brain-barrier and binding to H1-receptors in the central … nervous system. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and … rhinitis, allergic conjunctivitis, and urticaria. H1-antihistamines act on H1 receptors in T-cells to … inhibit the immune response, in blood vessels to constrict dilated blood vessels, and in smooth

Matched Description: like age-related macular degeneration (AMD) and diabetic macular edema (DME) by targeting both … vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2). These diseases often result from … retinal ischemia and the subsequent formation of new blood vessels (neovascularization). While … existing treatments like aflibercept and ranibizumab focus solely on inhibiting VEGF-A, faricimab's … unique mechanism involves binding to and depleting both VEGF-A and Ang-2. This dual action is aimed at

Matched Description: endothelial cells, the gastrointestinal tract, and immune cells. Unlike the first-generation … and causes a decrease in vascular permeability (prevents edema and flushing), decreases smooth muscle … tone (bronchodilation), and decreases the activation of the peripheral nociceptive receptors … (decreases pain and pruritus). At high concentrations, second-generation antihistamines such as loratadine … can inhibit histamine release from mast cells and basophils, thereby reducing ICAM-1 expression in

Matched Description: was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be … effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria … action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In … Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to … PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering

Matched Description: was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be … effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria … . It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia … coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs … 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with

Matched Description: was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be … effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria … . It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia … coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs … 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with